1. Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects
- Author
-
Enea Ferlizza, Elena Nardi, Mattia Lauriola, Michela Sgarzi, Rossella Miglio, Rossella Solmi, Gabriella Mattei, Ferlizza, Enea, Solmi, Rossella, Miglio, Rossella, Nardi, Elena, Mattei, Gabriella, Sgarzi, Michela, and Lauriola, Mattia
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Multinomial logistic model ,COL1A2 ,Colorectal cancer ,TSPAN8 ,Colonoscopy ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,CEACAM6 ,Blood markers ,lcsh:Science (General) ,Blood mRNA ,lcsh:R5-920 ,Multidisciplinary ,Receiver operating characteristic ,medicine.diagnostic_test ,Faecal immunochemical test ,business.industry ,medicine.disease ,030104 developmental biology ,Real-time polymerase chain reaction ,Colorectal cancer screening ,030220 oncology & carcinogenesis ,business ,lcsh:Medicine (General) ,LGALS4 ,lcsh:Q1-390 - Abstract
Prevention is essential to reduce Colorectal Cancer (CRC) mortality. We previously reported a panel of four genes: CEACAM6, LGALS4, TSPAN8, COL1A2 (CELTiC) able to discriminate patients with CRC. Here, we assessed the CELTiC panel by quantitative polymerase chain reaction, in the blood of 174 healthy subjects, who resulted negative to the faecal immunochemical test (FITN). Using non-parametric statistic and multinomial logistic models, the FITN were compared to previously analysed subjects: 36 false positive FIT (NFIT), who were negative at colonoscopy, 36 patients with low risk lesions (LR) and 92 patients with high risk lesions or CRC (HR/CRC). FITN showed a significantly lower expression of the four genes when compared to HR/CRC. Moreover, FITN showed a significantly lower expression of TSPAN8 and COL1A2 compared to NFIT and LR patients. The multinomial logistic model confirmed that TSPAN8 alone specifically discriminated FITN from NFIT, LR and HR/CRC, while LGALS4 was able to differentiate FITN from false positive FIT. Finally, ROC curves analysis of the comparisons between FITN and HR/CRC, LR or NFIT reported AUC greater than 0.87, with a sensitivity and specificity of 83% and 76%, respectively. The CELTiC panel was confirmed a useful tool to identify CRC patients and to discriminate false FIT positive subjects.
- Published
- 2020